Core collapse supernovae are thought to be one of the main sources in the galaxy of elements heavier than iron. Understanding the origin of the elements is thus tightly linked to our understanding of the explosion mechanism of supernovae and supernova nucleosynthesis. X-ray and gamma-ray observations of young supernova remnants, combined with improved theoretical modeling, have resulted in enormous improvements in our knowledge of these events. The isotope 44 Ti is one of the most sensitive probes of the innermost regions of the core collapse engine, and its spatial and velocity distribution are key observables. Hard X-ray imaging spectroscopy with the Nuclear Spectroscopic Telescope Array (NuSTAR) has provided new insights into the structure of the supernova remnant Cassiopeia A (Cas A), establishing the convective nature of the supernova engine. However, many questions about the details of this engine remain. We present here the concept for a balloon-borne follow-up mission called ASCENT (A SuperConducting ENergetic x-ray Telescope). ASCENT uses transition edge sensor gamma-ray microcalorimeter detectors with a demonstrated 55 eV Full Width Half Maximum (FWHM) energy resolution at 97 keV. This 8-16-fold improvement in energy resolution over NuSTAR will allow high resolution imaging and spectroscopy of the 44 Ti emission. This will allow a detailed reconstruction of gamma-ray line redshifts, widths, and shapes, allowing us to address questions such as: What is the source of the neutron star "kicks"? What is the dominant production pathway for 44 Ti? Is the engine of Cas A unique?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.